Top news of the day across the health care landscape.
All News
Advertisement
Top news of the day across the health care landscape.
Advertisement
Study results show a genetic risk variant on astrocytes enhances the accessibility of the central nervous system (CNS) to peripheral immune cells, escalating the risk of autoimmune inflammation and multiple sclerosis.
Survivors of Hodgkin Lymphoma have higher incidence rates of breast, lung, colorectal, and thyroid cancer later in life compared with the general population, new study says.
Aurobindo Pharma USA is voluntarily recalling 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP to the consumer level, due to the detection of trace amounts N-nitrosodiethylamine.
Looking ahead, there are a plethora of promising new treatments for a range of specialty conditions in the 2019 drug pipeline.
Advertisement
Advertisement
Top news of the day across the health care landscape.
Top news of the day across the health care landscape.
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
3
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
4
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
5
